TRIGYN — Trigyn Technologies Balance Sheet
0.000.00%
- IN₹2.38bn
- -IN₹1.34bn
- IN₹12.80bn
- 94
- 98
- 29
- 88
Annual balance sheet for Trigyn Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,296 | 1,964 | 2,151 | 1,381 | 3,829 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,656 | 2,455 | 2,915 | 3,785 | 2,584 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,101 | 4,618 | 5,178 | 5,518 | 6,823 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 52.8 | 60.4 | 85.7 | 116 | 75.1 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6,179 | 6,829 | 7,549 | 8,561 | 8,737 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,045 | 1,149 | 1,402 | 1,640 | 1,603 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,144 | 1,248 | 1,473 | 1,751 | 1,725 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 5,035 | 5,581 | 6,076 | 6,810 | 7,012 |
Total Liabilities & Shareholders' Equity | 6,179 | 6,829 | 7,549 | 8,561 | 8,737 |
Total Common Shares Outstanding |